Bank of America Securities analyst Victoria Petrova has maintained their bullish stance on HLN stock, giving a Buy rating on November 4.
Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback